Meet the directors 

The names of our Trust board members are detailed below, together with a declaration of their relevant interests.

Non-executive directors
Richard Murley

Richard Murley

Richard was appointed as chairman in July 2010 having previously served as a non-executive director from November 2008. He was reappointed in November 2012 for a further three years commencing in July 2013. Subsequently, in April 2015, his term of office was extended by a further year to the end of June 2017. Subsequently, in July 2016, his term of office was extended again by the Council of Governors to the end of December 2017. Richard is a qualified solicitor and has worked in the City of London for more than 30 years. He is a vice-chairman of Rothschild where he has worked since 2006. Between 2003 and 2005, he was director general of the Panel on Takeovers and Mergers, regulating the conduct of takeovers of public companies in the UK. As well as chairing the Board, Richard is a member of the Finance & Contracting Committee, the Quality & Safety Committee and the Investment Committee.
 
Declaration of interests:
  • Executive vice-chairman, global Financial Advisory, NM Rothschild & Sons Limited
  • Trustee, Crisis
  • Board member, UCLPartners
  • Chairman, United Trust Bank.

back to top


Dr Harry Bush CB

Dr Harry Bush CB, non-executive director (vice chairman)

Harry was appointed to the Board in February 2012; he was reappointed in February 2015 for a further three years. He has extensive senior management experience at HM Treasury and in the economic regulation of the aviation industry. He was most recently a member of the Civil Aviation Authority Board with executive responsibility for the Authority’s economic output. Prior to that, he held a number of senior posts at HM Treasury during a long career there. Harry was appointed vice-chair of the Board and is chair of the Finance & Contracting Committee. He is a member of the Audit and Investment Committees.

Declaration of interests:

  • Director, Directgreen Property Management Ltd
  • Director, H2B2 Ltd
  • Non-executive director, The Airline Group Ltd
  • Non-executive director, NATS Holdings Ltd.
  • Director, NATS Employee Sharetrust Ltd
  • Part-time advisory consultant, KPMG.

back to top


Althea Efunshile

Althea Efunshile CBE

Althea was appointed to the board in May 2016. She has had a 30-year career in local and central government, during which she gained extensive senior management experience. She is deputy chief executive at Arts Council England where she is responsible for the national investment strategy, corporate governance and operational delivery. Prior to that she held a number of director level posts within the Department for Education all of which were concerned with improving outcomes for disadvantaged children and young people. She has been the executive director for education and culture in the London Borough of Lewisham,  and assistant director of education in the London Borough of Merton.
 
Althea was awarded a CBE for services to art and culture in the 2016 Queen’s birthday honours.
 
Declaration of interests:
  • Board member, Goldsmiths College, University of London
  • Chair of the National College for Cultural and Creative Industries

back to top


David Lomas

Prof David Lomas, non-executive director

David was appointed to the Board from September 2015 as the nominee from UCL.  He is Vice Provost (Health), Head of the UCL School of Life and Medical Sciences and Head of UCL Medical School and works as a respiratory physician at UCLH.  He received his medical degree from the University of Nottingham and undertook his PhD at Trinity College, Cambridge. He was an MRC Clinician Scientist, University Lecturer and Professor of Respiratory Biology in Cambridge before moving to UCL in 2013 to be Chair of Medicine and Dean of the Faculty of Medical Sciences.  He is chair of the Population and Systems Medicines Board at the Medical Research Council and previously chaired the Respiratory Therapy Area Unit Board at GlaxoSmithKline.  He is a National Institute for Health Research Senior Investigator.  David's research interests are the pathobiology of α1-antitrypsin deficiency, the serpinopathies and COPD.
David chairs the UCLH Quality and Safety Committee

Declaration of interests: 

  • President of the Association of Physicians of Great Britain and Ireland, 2017-18
  • UCL Stakeholder representative on Imanova Board
  • UCL representative and Director of the KwaZulu Natal Research Institute for TB-HIV (K-RITH) Grants Advisory Committee
  • Patron, Alpha1 Awareness UK
  • Honorary Senior Treasurer, National Student Association of Medical Research
  • Scientific Advisory Committee, Genomics England
  • Chair, UK Respiratory Research Collaborative
  • GSK COPD Disease Model Steering Group
  • Member, Expert Advisory Group, Innovative Medicines and MedTech Review for the Minister of Life Sciences.
  • Founders Board, Francis Crick Institute
  • Board member, UCLPartners
  • Director, GMEC Management Company Ltd

back to top


Dr Rima Makarem

Dr Rima Makarem, non-executive director

Rima joined the Board in July 2013 and was appointed as chair of the Audit Committee on 1 January 2014. In July 2016 she was reappointed for a further three years to 31 December 2019. Rima has extensive experience in healthcare and the pharmaceutical industry. She currently runs her own interim management and consultancy business and holds a portfolio of non-executive positions. These include: trustee of UCLH Charity; board director at Anchor Trust; and associate board member/ chair of the Risk Assurance Committee at Health Education South London. She was until recently the audit chair at NHS London and at NHS Haringey before that. Previously Rima was director of competitive excellence at GlaxoSmithKline and prior to that, a management consultant. Rima holds a PhD in Biochemistry and an MBA from INSEAD business school. Rima chairs the Audit Committee.

Declaration of interests:
  • Director and owner, Healthpeak Limited
  • Non-executive director, Anchor Trust
  • Trustee, UCLH Charity
  • Chair, National Travel Health Network and Centre
  • Independent Member of Council at St. George’s, University of London.

back to top


Kieran Murphy

Kieran Murphy

Kieran was appointed to the Board from January 2014 for a period of three years. He was subsequently reappointed for a further three years to 31st December 2019. He graduated from Cambridge University and began his career as a civil servant at HM Treasury. Subsequently he joined Kleinwort Benson where he spent 15 years as a senior corporate finance adviser, culminating in leadership of the worldwide industrial sector investment banking business. Kieran joined the corporate finance advisory firm Gleacher Shacklock as a partner in 2004 and subsequently became a senior adviser prior to his retirement from the firm in December 2015. He is also a board member at City University, London, where he chairs the Strategy Implementation and Performance Committee. Kieran chairs the Investment Committee and is a member of the Audit and Finance and Contracting Committees.

Declaration of interests:

  • Board member, City University
  • Board member, University of London
  • Non-executive director, Aliaxis S.A.
  • Chairman, Ordnance Survey.

back to top


Dr Diana Walford CBE

Dr Diana Walford CBE, non-executive director

Diana joined the Board in December 2011; she was reappointed for a further three years from December 2014. She has a distinguished record at the highest level in the civil service, NHS and higher education. During her career she served the NHS as deputy chief medical officer for England, director of healthcare for the NHS Management Executive, director of the Public Health Laboratory Service and non-executive director of the NHS Blood and Transplant Authority. Diana is also a qualified haematologist and epidemiologist and was an honorary consultant haematologist at the Central Middlesex Hospital. Most recently, she was the principal of Mansfield College, Oxford University. Diana is a member of the Audit Committee and the Quality & Safety Committee.

Declaration of interests:

  • Chair of the Board of Trustees, Regent’s University London
  • Deputy chairman, Council of the London School of Hygiene and Tropical Medicine
  • Trustee, Sue Ryder.

back to top


Mr Caspar Woolley

Mr Caspar Woolley, non-executive director

Caspar was appointed to the Board for an initial three year period commencing January 2015. Caspar is a Cambridge graduate who started his career as a design engineer. He founded and is a Board member at Hailo Network Ltd, the taxi app. He also served as the chief executive officer of E-Courier (UK) Ltd and led the eCourier.co.uk management team. He was also vice president for Fleet at Avis. Previously, he served as the head of business development for The John Lewis Partnership. He served as vice president of operations at buy.com (UK) Ltd. He has been an independent non-executive director of GAME Digital plc since 16 May 2014. He has also been a governor at a foundation trust. Caspar is a member of the Investment Committee.
 
Declaration of interests:
  • Non-Executive Director, GAME Digital plc
  • Board member, Hailo Network Ltd and subsidiaries
  • Director, BeautySorted Ltd.

back to top


Executive directors
Sir Robert Naylor

Sir Robert Naylor, chief executive

Robert Naylor has been chief executive at UCLH since November 2000. He will step down at the end of September 2016. He led the development of one of the largest building projects in the NHS to create the world-class University College Hospital, which was handed over to UCLH in two phases in 2005 and 2008. In April 2012 UCLH opened the third phase of development – the new University College Hospital Cancer Centre. In recent years UCLH has achieved many accolades for high-quality care, most notably in the Dr Foster league tables. In collaboration with UCL, UCLH is recognised as one of the leading academic medical centres in the world. It was designated one of the five Biomedical Research Centres and is a founding member of UCLPartners, an Academic Health Science Centre. Robert was awarded a knighthood for services to healthcare by Her Majesty The Queen in the New Year Honours List 2008. He has been a chairman of a number of national and regional committees and was awarded an honorary doctorate by Greenwich University in 2009.

Declaration of interests:

  • Member, NHS Confederation Policy Board
  • Member, NHS Procurement and Efficiency Board (Carter Review)
  • Director, Robert Naylor Consulting Ltd
  • Trustee, N. Sethia Foundation (UK Charity)
  • Advisory work for Everlight Radiology (Australia)

back to top


Prof Geoff Bellingan

Prof Geoff Bellingan, medical director, surgery and cancer board

Geoff was appointed as medical director in September 2009. He trained as a chest physician and then in intensive care in which he has been a consultant at UCLH since 1997. He obtained his PhD studying inflammatory cell biology as a Medical Research Council training fellow at the University of Edinburgh and received a clinician scientist award to continue his research at UCL. He is a reader in intensive care medicine at UCL and leads on several multinational clinical trials in acute respiratory distress syndrome and critical care. Geoff has a strong interest in medical leadership. He became divisional clinical director for theatres and anaesthesia in 2006 and from 2008/09 he was divisional clinical director for emergency services. As medical director for surgery and cancer, Geoff has a particular interest in the strategic plans for cancer care across north and east London, working closely with London Cancer, Macmillan and a number of other major partners. This led to the successful UCLH Cancer Vanguard application and the award of a National Cancer Vanguard in partnership with Manchester cancer (the Christie Hospital) Royal Marsden and partners and UCLH cancer. Geoff is also the senior responsible officer for the new Phase 4 project, which incorporates the UK’s first Proton Beam Therapy unit, expansion of theatres and a new cancer hospital.


Declaration of interests:
  • Co-director, London Intensive Care Ltd
  • Board member, London Cancer
  • Board member, London Clinical Senate
  • Member, Adult Critical Care Clinical Reference Group
  • Member of Medical Advisory Committee, London Clinic
  • Member, Patient Safety Committee, Royal College of Physicians
  • Member, Medical Equivalence Committee, Faculty of Intensive Care Medicine.

back to top


Dr Gill Gaskin

Dr Gill Gaskin, medical director, specialist hospitals board

Gill Gaskin was appointed medical director of the Specialist Hospitals Board in January 2010, leading clinical services at the NHNN, the HH (prior to the transfer of cardiovascular services to Barts Health), the EDH, the RNTNEH and in women’s health and paediatric and adolescents. Gill graduated from Cambridge and trained in renal and general medicine at Hammersmith Hospital and the Royal Postgraduate Medical School, completing a PhD on the biology of systemic vasculitis. Between 1995 and2010 she held consultant-level posts at Imperial College, Hammersmith Hospitals and Imperial College Healthcare Trusts, with additional responsibilities as director of postgraduate medical education and professional development, clinical director and latterly director for the medicine clinical programme group. She was renal training programme director for North London for four years and was also a member of the London Workforce Advisory Forum. Gill is a member of the Faculty of Medical Leadership and Management and is a participant in the NHS Top Leaders Programme.


Declaration of interests:
  • Honorary consultant, Imperial College Healthcare NHS Trust

back to top


Neil Griffiths

Neil Griffiths

Neil Griffiths was appointed deputy chief executive in June 2014. Neil has over 20 years hospital management and leadership experience having joined the NHS from Bristol University in 1992. He has held operational, commercial and strategic roles in a number of different hospitals, including Lewisham, St Mary’s (now part of Imperial), East Kent andthe Royal National Orthopaedic. Neil also previously worked at UCLH from 2003-08. In addition to his NHS hospital experience Neil has spent six years working in the private healthcare sector, most recently as a member of the healthcare management consultancy team at McKinsey & Company. Neil helped develop the McKinsey Hospital Institute in the UK which was created to support NHS hospitals identify improvement opportunities and with the delivery of change and productivity programmes. As well as a number of functional leadership responsibilities, an important component of the role of deputy CEO is the development and implementation of the trust-wide transformation programme, ‘uclh future’.

Declaration of interests:

  • Former employee, McKinsey & Company.
  • Director, MY UCLH
  • Member, NHS Staff College Board

back to top


Dr Charles House

Dr Charles House, interim medical director, medicine board

Charles took up the post of interim Medical Director in March 2016.  He studied medicine at St. Mary’s Hospital Medical School and trained in radiology at UCLH, being appointed here as consultant radiologist in 2005, with subspecialist interests in bone and soft tissue sarcoma, myeloma and orthopaedic imaging.  After spells as College Tutor for the UCLH radiology training scheme and clinical lead in radiology, Charles became Divisional Clinical Director of Imaging in 2011.  He was appointed as Associate Medical Director in November 2014, a role with specific responsibilities in operational inpatient services, resource management and Trust-wide improvement schemes.
 
Charles has a keen interest in clinical leadership and evolving models of healthcare, with focus on collaboration between organisations and across sectors.
 
Declaration of interests:
  • No interests to declare

back to top


Tim Jaggard

Tim Jaggard

Tim was appointed as Finance Director at UCLH in April 2016, following a period as Interim Finance Director from July 2015 and prior to that a five year period as Deputy Finance Director at the trust. He joined UCLH from the Whittington where he was Deputy Finance Director for two years. Prior to this Tim held senior finance positions in the areas of service line reporting, patient level costing, commissioning and financial management following graduation from the NHS graduate training scheme in 2006. He has a degree in Psychology from Cambridge which was followed by further study at the Judge Business School.
 
Declaration of interests:
  • No interests to declare

back to top


Professor Tony Mundy

Professor Tony Mundy, corporate medical director

Tony has been a medical director since 2001. Since November 2006 he has been the corporate medical director with UCLH-wide responsibility for quality and safety and for research and development. He is the UCLH responsible officer for the revalidation of doctors under the GMC registration regulations. He was previously clinical director of urology and nephrology and then medical director for medicine and surgery from 2001 to 2006. Tony is a professor of urology in the University of London and director of the Institute of Urology.

Declaration of Interests:

  • No interests to declare.

back to top


Flo Panel-Coates

Flo Panel-Coates

Flo was appointed UCLH chief nurse in April 2015, coming to the organisation from Barking, Havering and Redbridge University NHS Trust where she was chief nurse for two and a half years. Prior to that she was director of nursing and quality at Maidstone and Tunbridge Wells NHS Trust from August 2008 until September 2012, and director of nursing and midwifery, and director of infection prevention and control,  at the North Middlesex University Hospital NHS Trust from September 2005 to August 2008. She has a keen interest in organisational culture and in creating different ways of working to release more time to care.
 
Declaration of Interests:
  • Non-executive director of NHS Innovations South East, since January 2012, and chair of its finance committee
  • Invited Member, London Leadership Academy Reference Group
  • Member (and Chair from August 2015), The Executive Nursing Network

back to top


Other directors who attend the Board
Mr Ben Morrin

Mr Ben Morrin, Director of Workforce

Ben joined UCLH as the Director of Workforce in September 2014.  In the preceding decade he worked across the Department of Health and within the Prime Minister’s Delivery Unit.  Ben is a Fellow of the Chartered Institute for Personnel and Development and a member of the London Workforce Senate.
 
Declaration of Interests:
 
  • Wife is a civil servant employed at the Department of Health and Trustee of Cruse

back to top